Acadia Healthcare vs National HealthCare
ACHC and NHC side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACHC and NHC compare
National HealthCare is the larger company, worth 1.2 times as much as Acadia Healthcare ($3.2B against $2.8B).
National HealthCare grew revenue faster over the last twelve months (6.9% versus 4.3% for Acadia Healthcare).
National HealthCare keeps more of each dollar of sales as profit, with a net margin of 9.0% compared with −33.4% at Acadia Healthcare.
National HealthCare pays a dividend yielding 1.3%; Acadia Healthcare does not pay one.
National HealthCare scores higher on the StockData Score (21 against 7 for Acadia Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACHC | NHC |
|---|---|---|
| Size and price | ||
| Market cap | $2.8B | $3.2B |
| Share price | $29.96 | $206.14 |
| Change, 1 year | 30.2% | 70.6% |
| Change, 5 years | −53.3% | 170% |
| Beta (5Y) | 0.65 | 0.44 |
| Employees | 25K | 15K |
| StockData Score | ||
| Total score | 7 | 21 (better) |
| Valuation score | 3 (better) | 2 |
| Growth score | 2 | 4 (better) |
| Performance score | 0 | 5 (better) |
| Health score | 2 | 6 (better) |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | – | 23.2× |
| P/S | 0.8× (better) | 2.1× |
| P/B | 1.4× (better) | 2.9× |
| EV/EBITDA | – | 16.8× |
| P/FCF | – | 22.0× |
| PEG | – | 0.31 |
| FCF yield | −4.8% | 4.5% (better) |
| Fair value | $67.36 | $170.67 |
| Margin of safety | 55.5% (better) | −20.8% |
| Growth | ||
| Revenue growth (TTM) | 4.3% | 6.9% (better) |
| Revenue growth, 5Y average | 9.7% (better) | 8.1% |
| Net income growth (TTM) | −909% | 33.8% (better) |
| EPS growth (TTM) | −938% | 32.5% (better) |
| EPS growth, 5Y average | – | 23.0% |
| Profitability | ||
| Operating margin | – | 9.3% |
| Net margin | −33.4% | 9.0% (better) |
| FCF margin | −4.0% | 9.4% (better) |
| Return on equity | −44.5% | 13.1% (better) |
| Return on invested capital | – | 10.6% |
| Financial health | ||
| Debt / equity | 1.22 (better) | 0.00 |
| Net debt / EBITDA | – | −0.21 |
| Interest coverage | – | 56.6× |
| Current ratio | 1.57 | 1.86 (better) |
| Altman Z-score | 0.98 | 7.03 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 1.3% |
| Payout ratio | – | 28.4% |
| Years of dividend growth | – | 12 |
| Dividend growth, 5Y average | – | 4.0% |
| Buyback yield | – | 0.15% |
| Shareholder yield | 0.00% | 1.4% (better) |
| Ownership | ||
| Held by institutions | 145% | 65.3% |
| Held by insiders | 1.9% | 9.3% |
| Insider net buying, 12 months | – | −$11.0M |
| Short interest, % of float | 24.9% | 5.8% |
Go deeper
- ACHC stock overview
- ACHC income statement
- ACHC valuation and score
- NHC stock overview
- NHC income statement
- NHC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.